LeafNLP Demos
Back to explore

Report #2861508

Received Oct 30, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
17 yrs
State
TN
Recovered
Unknown
Vaccinated
Sep 22, 2025
Onset
Sep 22, 2025
Days to onset
0
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
MENMENINGOCOCCAL (NO BRAND NAME)UNKNOWN MANUFACTURER1U8493AAOT / LA
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNK—OT / RA
MENMENINGOCOCCAL (NO BRAND NAME)UNKNOWN MANUFACTURERUNKU8493AAIM / LA
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNKUNK—

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

received MENQUADFI and Menveo, both meningococcal A, C, W, Y conjugate vaccines, on the same day with no reported AE; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of overdose in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included Meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) (batch number U8493AA, expiry date 30-MAY-2028) for prophylaxis. On 22-SEP-2025, the patient received Menveo and Menquadfi (intramuscular, left arm) .5 ml. On 22-SEP-2025, an unknown time after receiving Menveo and Menquadfi, the patient experienced overdose (Verbatim: received MENQUADFI and Menveo, both meningococcal A, C, W, Y conjugate vaccines, on the same day with no reported AE). The outcome of the overdose was not applicable. Additional Information: GSK Receipt Date:13-OCT-2025 The patient had not reported any adverse reaction.